How do you store lyophilized peptides?
Sealed lyophilized peptide vials are stored at controlled room temperature for short-term holding (typical 4-week window) and refrigerated or frozen for longer-term storage (months to years). The intact inert-gas headspace in the sealed vial is the primary stability mechanism — once the seal is broken at reconstitution, the post-reconstitution storage protocol takes over.
What the research literature says
Lyophilization removes the water from a frozen peptide solution by sublimation, leaving a dry porous solid that is far more stable than the original aqueous solution. The Wang lyophilization review consolidates the physical-chemistry basis for the long-term dry-form stability: removing the water substrate eliminates the substrate for most peptide-degradation pathways including hydrolysis, deamidation, and aggregation (PMID 10967427). Properly lyophilised peptide held under cool, dry, light-protected conditions in a sealed container under inert gas can show multi-year stability, with the exact shelf life depending on the peptide’s intrinsic structural stability and the storage conditions (PMID 15032301).
Three storage tiers are referenced across the published research-handling literature. Controlled room temperature (15-25 °C, dry, dark) is appropriate for short-term holding of unopened vials between manufacture, shipping, and immediate use. Refrigerated storage (2-8 °C) is the default for unopened vials held beyond the short-term window and for reconstituted peptide in working solution. Frozen storage (-20 °C or colder) is the default for long-term archival of unopened vials and for aliquoted reconstituted peptide in single-use portions sized to minimise freeze-thaw cycle exposure.
The critical operational point: the lyophilised form is dramatically more stable than the reconstituted form. The integrity of the inert-gas-headspace seal and the absence of water inside the vial are the two physical conditions that underwrite the multi-year stability stated on commercial vials.
Why this matters in research context
Most research-peptide handling errors occur at the reconstitution step or in post-reconstitution storage rather than in pre-reconstitution handling. The lyophilised stock is forgiving — ambient or refrigerated transit, controlled room temperature short-term holding, and refrigerated or frozen long-term storage all maintain stability. The reconstituted solution is much less forgiving and benefits from aliquoting into single-use portions and frozen storage between draws. The full handling protocol covering pre-reconstitution and post-reconstitution storage for the catalog compounds is in the peptide storage guide.
Related compounds
This question applies to every lyophilised peptide in the Ronin catalog. The full catalog is on the shop page. Per-compound storage recommendations are in the Storage and handling accordion on each product page.
Related research questions
- How long does reconstituted semaglutide last?
- How much bacteriostatic water with BPC-157?
- Can BPC-157 be stacked with TB-500?
References
- Wang W. Lyophilization and development of solid protein pharmaceuticals. International Journal of Pharmaceutics 2000;203(1-2):1-60. [PMID 10967427]
- Carpenter JF, Pikal MJ, Chang BS, Randolph TW. Rational design of stable lyophilized protein formulations: some practical advice. Pharmaceutical Research 1997;14(8):969-975. [PMID 9279875]
- Tang X, Pikal MJ. Design of freeze-drying processes for pharmaceuticals: practical advice. Pharmaceutical Research 2004;21(2):191-200. [PMID 15032301]
- ICH Q1A(R2) — Stability Testing of New Drug Substances and Products. Container/closure considerations for shelf-life claims.
Research-questions pages describe research-context use of peptide-research terminology. They do not constitute medical, veterinary, or clinical advice. Every compound in the Ronin catalog is sold strictly for laboratory and research use only.